Introduction {#Sec1}
============

The lung is the key organ of gas exchange in mammals; it undertakes the transport of oxygen from inspired air into the bloodstream and, concomitantly, the transport of carbon dioxide out of the circulating blood, which is subsequently exhaled and thus removed from the body. This gas exchange is facilitated by the highly organized structure of the alveolus, the gas-exchange unit of the lung, where the inspired air is brought into close proximity to the circulating blood (Hsia et al. [@CR47]). The close proximity of air and blood is facilitated by the delicate alveolo-capillary barrier, a double-layered barrier consisting of alveolar epithelial cells that line the alveolar units containing the inspired air and that are intimately associated with the endothelial cells that form the capillaries of the pulmonary circulation carrying deoxygenated blood through the lung (Hsia et al. [@CR47]). The blood-air barrier is very thin, namely 200 nm--2 μm and is permeable to many gases including oxygen and carbon dioxide, thus facilitating gas exchange. Gas exchange occurs by Fick's Law (Fick [@CR36]) and is a passive process that is directly determined by (1) the surface area available over which the gases can diffuse, (2) the distance across which the gas molecules must diffuse and (3) the concentration gradient. The broader objective of lung development is to generate a gas-exchange structure that satisfies these three conditions. The structure should have a large surface area and a thin diffusion barrier and should facilitate the establishment of a steep concentration gradient for gas diffusion in the correct direction. To this end, lung development is initiated with the emergence of the respiratory diverticulum, which is a ventral outgrowth of the foregut endoderm, very early during embryonic development (the fourth week of gestation in humans). Tracheo-esophageal ridges form from longitudinal mesodermal folds that "pinch off" to separate the trachea from the esophagus (Herriges and Morrisey [@CR43]; Morrisey et al. [@CR80]; Morrisey and Hogan [@CR79]; Warburton et al. [@CR127]). Lung development then proceeds via the formation of the trachea, which subsequently generates the bronchial tree, forming the conducting airways that develop largely in parallel with the vasculature that forms the pulmonary circulation (Rawlins [@CR103]). Subsequent lung development over the canalicular, saccular and alveolar stages generates the alveolar gas-exchange units (Morty et al. [@CR81]). To satisfy the needs of Fick's Law, lung development strives to generate (1) a large number of small alveoli, thus producing an extremely large gas-exchange surface area and (2) as thin an alveolo-capillary barrier as possible to minimize the distance that the diffusing gases must transit. Furthermore, the proper development of the conducting airways and conducting blood vessels allows continuous blood flow in the capillaries and constant air flow (by breathing) thereby maintaining a steep concentration gradient at the site of the alveolo-capillary barrier. When lung development proceeds correctly, the lung structure that is generated is perfectly suited to provide optimal gas exchange (Herriges and Morrisey [@CR43]; Warburton et al. [@CR128]; West [@CR130]).

Perturbations to lung development result in lungs that are defective for optimal gas exchange. These perturbations result in a clinically relevant disease, the most prevalent of which is bronchopulmonary dysplasia (BPD; Kinsella et al. [@CR59]; Martin and Fanaroff [@CR72]), a common complication of preterm birth originally described by Northway and coworkers in 1967 (Northway et al. [@CR87]). Preterm infants often present with acute respiratory failure (neonatal or infant respiratory distress syndrome) that requires oxygen supplementation, in the most extreme cases, by mechanical ventilation. In affected infants, a combination of infection, inflammation and oxygen toxicity, together with physical forces generated by baro- and volu-trauma from mechanical ventilation, appreciably stunts the post-natal growth and maturation of the developing lung (Jain and Bancalari [@CR51]). Over many years, because of changes in the medical management of pre-term birth, the histopathological picture of BPD has changed, moving from lung damage caused by aggressive mechanical ventilation and oxygen toxicity ("old BPD") to a pathology that is distinctly characterized by disturbances to lung developmental pathways ("new BPD"; Day and Ryan [@CR32]). This stunting impacts all elements of lung development and the blunted alveolar development generates fewer alveoli of a larger size; hence, the gas-exchange surface area is smaller than it should be. Additionally, lungs from affected infants are characterized by thickened alveolar walls, which increase the gas-diffusion distance between the inspired air in the alveoli and the circulating blood in the capillaries. Furthermore, a dysmorphic pulmonary vasculature develops, which may cause pulmonary hypertension, thus complicating blood flow through the lung (Baker and Abman [@CR11]; Hadchouel et al. [@CR41]). BPD is associated with significant morbidity and mortality in the neonatal intensive care unit and survivors exhibit long-term consequences that persist into adulthood (Baraldi and Filippone [@CR12]; Hilgendorff and O'Reilly [@CR44]; Wong et al. [@CR135]). Disturbances to alveolar structure and to the pulmonary vasculature are not exclusive to BPD and can also be seen in infants with congenital diaphragmatic hernia (CDH; Sluiter et al. [@CR112]; Veenma et al. [@CR123]). The improvements in the medical management of preterm birth underlying the transition from "old BPD" to "new BPD" have paradoxically led to an increase in the incidence of BPD, because preterm infants born earlier and earlier now survive better (Jobe [@CR53], [@CR54]; Jobe and Ikegami [@CR56]; Madurga et al. [@CR66]; Northway [@CR86]); for example, preterm infants born in the 25--28 week range now have \>90 % survival (Stoll et al. [@CR113]). Thus, BPD represents an increasing clinical burden, underscoring the need for a better understanding of the aberrant lung development in affected neonates. Whereas autopsy material from BPD non-survivors presents one avenue for the exploration of pathogenic mechanisms at play in the lungs of affected patients, this material is increasingly rare and difficult to obtain, because the survival rate of BPD patients has steadily improved over time. Therefore, most studies addressing pathogenic mechanisms that drive BPD pathology are performed in experimental animals. These experimental animal models of BPD also serve as an important means of evaluating candidate therapeutic interventions, such as novel lead compounds for drug development.

State of the art: pros and cons of animal models of BPD {#Sec2}
=======================================================

Modeling BPD in experimental animals has been the subject of a large number of recent reviews; therefore, no attempt will be made here to re-review all of the available models. For this, the reader is directed to a series of state-of-the-art reviews on modeling BPD in mice (Berger and Bhandari [@CR15]), rats (O'Reilly and Thébaud [@CR90]), rabbits (D'Angio and Ryan [@CR30]; Manzano et al. [@CR70]), pre-term lambs (Albertine [@CR5]), pre-term pigs (Arrindell et al. [@CR9]; Caminita et al. [@CR23]) and baboons (Yoder and Coalson [@CR136]). Additionally, the utility of these models for the study of disease mechanisms (Hilgendorff et al. [@CR45]) and therapy development (Jobe [@CR55]) has also recently been reviewed.

BPD is most commonly modeled in mice and rats. The reasons for this are manifold. Mice and rats have relatively short gestation times (Table [1](#Tab1){ref-type="table"}) and thus, studies that monitor post-natal lung maturation can be conducted relatively quickly, since lung development in both mice and rats is largely complete within the first 2 and 3 weeks of life, respectively. Additionally, several other practical advantages to working with mice and rats can be mentioned: both mice and rats are readily available and easy to maintain compared with larger vertebrates. Moreover, fewer concerns are raised by regulatory agencies against experimental studies on rats and mice, than, for example, experimental studies on non-human primates. Mice additionally offer a wide availability of many transgenic lines, although the advent of the CRISPR/Cas9 system should make the generation of transgenic animals such as rats both easier and cheaper. The smaller size of mice and rats means that smaller amounts of pharmacological agents are required compared with the same dosing of an agent in a larger animal.Table 1Stages of mouse and rat lung development compared with that of humans (*E* embryonic day, *P* postnatal day)StageGestational ageMouse\
(days)Rat\
(days)Human\
(weeks)EmbryonicE9-E11.5E8-E133--7PseudoglandularE11.5-E16.5E18-E185--17CanalicularE16.5-E17.5E18-E2016--29SaccularE17.5-P5E20-P524--38AlveolarP5-P28P5-P3032-adolescence

Both mice and rats are delivered at term in the saccular stage of lung development; this fact is often used to justify the superiority of mice and rats as model animals for BPD, since preterm infants that develop BPD are also delivered in the saccular stage of lung development. Thus, term mouse and rat models appear to be useful models of pre-term birth. However, we should also keep in mind that, when term mice and rats are delivered in the saccular stage, these newborn rodent pups are competent for proper gas exchange and do not require oxygen supplementation as a life-saving intervention; this is in marked contrast to preterm human neonates with or at risk for the development of BPD.

The small size of mice and rats at birth is also a disadvantage. Newborn mouse and rat pups are notoriously difficult to intubate. This is important, since mechanical ventilation is a highly clinically relevant, injurious stimulus for BPD. Thus, the maintenance of intubated ventilated newborn mouse and rat pups over prolonged periods of time is desirable in order to assess the impact on post-natal lung maturation. Tissue and cell stretch and lung distention are proposed to be important causes of tissue damage to the developing lung (Hussein et al. [@CR50]) emphasizing the need for more ventilation-based models to study the impact of mechanical ventilation on post-natal lung maturation. For example, an 8-h aggressive mechanical ventilation period (tidal volume 15 μl/g) of 5-day-old mouse pups with room air stunts lung alveolarization, whereas a comparatively gentler mechanical ventilation protocol (tidal volume 8 μl/g) does not impact alveolarization (Ratner et al. [@CR102]). Currently, mechanical ventilation can only be undertaken for short periods of time (up to about 24 h; Berger and Bhandari [@CR15]; Bland et al. [@CR17]) but not beyond. In this sense, the larger animal models are clearly superior.

The small size of newborn mouse and rat pups is also a source of concern with regard to substance administration. Parenteral administration of pharmacological agents generally must be via the intraperitoneal route, since intravenous injection in newborn mouse and rat pups is not possible. The small size and delicate skin of newborn mouse and rat pups also makes dosing frequency difficult. For substances with short half-lives, repeat dosing over short intervals is generally not possible, since repeated injection at the same injection site (one is short of options in newborn mouse pups) creates local trauma and necrosis and the placement of a mini-pump is impractical. These drawbacks again highlight the utility of the larger animal models of BPD. Scope for the improvement of the delivery of agents to newborn mouse pups does however exist. Whereas many pharmacological agents are short-lived, some chemical substances have pronounced in vivo stability. One case in point is that of antagomiRs, which are synthetic inhibitors of microRNA. MicroRNA are emerging as exciting modulators of normal and aberrant lung alveolarization (Nardiello and Morty [@CR85]). The extraordinary stability of antagomiRs makes antagomiRs suitable as test substances for examining, for example, delivery to newborn pups via the maternal route, shortly prior to birth. Such maternal transmission studies might markedly improve agent delivery to newborn rodent pups, although such studies have yet to be reported in the literature. Along these lines, other possible routes of the administration of pharmacological and other agents include the intra-nasal route, which would be particularly relevant in the case of respiratory viruses such as respiratory syncytial virus (RSV) and influenza virus, which are known to complicate clinical BPD. Additionally, the intrauterine administration of substances such as bacterial lipopolysaccharide has been employed, to assess an impact of sterile inflammation on post-natal lung alveolarization (Ueda et al. [@CR121]). To date, no side-by-side comparison has been published that has assessed the comparative efficacy of substance administration by using various routes of substance administration in utero, via the maternal route, or directly to newborns.

In spite of the drawbacks highlighted above, rodent models of BPD are the predominant model in widespread use today. This predominance has also led to a substantial variance in the injurious insults applied. A wide variety of mouse strains are available and many strains are employed on a mixed strain background. Whereas the C57BL/6 is the most widely-employed mouse strain, studies have also been reported involving BALB/c, FVB/n and C3H background strains and mixed backgrounds containing some 129S strain components (Silva et al. [@CR111]). This concerns hyperoxia studies, since tremendous variation is present in the susceptibility of adult mice of different strains to hyperoxia (Hudak et al. [@CR48]; Whitehead et al. [@CR131]). This use of diverse mouse strains sometimes makes the comparisons of independent studies problematic. A systematic comparison of the susceptibility of the various mouse strains to hyperoxia, particularly concerning the impact of hyperoxia and mechanical ventilation on post-natal lung maturation, is a study that urgently needs to be conducted in order to allow investigators to make informed decisions about which mouse strain might be useful in studies in experimental mouse models of BPD. The importance of this idea is underscored by the tremendous influence of the mouse strain on fibrogenic responses to transforming growth factor-β (Kolb et al. [@CR61]), which is a known mediator of aberrant lung development in the hyperoxia-based mouse model of BPD (Alejandre-Alcázar et al. [@CR6]; Nakanishi et al. [@CR84]).

Another area in which tremendous variation in animal models is evident is in the degree of oxygen injury employed. Term mouse and term rat models can be used, with a range of oxygen injury protocols being currently implemented. These are summarized (evaluating literature from the past 3 years) in Table [2](#Tab2){ref-type="table"}. Although the use of diverse oxygen injury protocols is fruitful, a standardized protocol would also be helpful so that studies undertaken by diverse groups can be directly compared side-by-side. To this end, a systematic comparison of the impact of various oxygen concentrations would be of great value for the community. In this respect, a study of the impact of gradual versus abrupt changes in inspired oxygen concentrations on lung alveolarization needs to be conducted in order to consider the translational implications of gradual weaning. Along these lines, from an animal welfare point of view, the determination of the "windows" of post-natal lung development that are sensitive to oxygen injury would be advantageous. Currently, many investigators simply expose newborn rodents to elevated oxygen concentrations for fixed periods of time, for example, from the day of birth to post-natal day (P)14, at which time point the bulk alveolarization that takes place over the immediate postnatal period is largely complete. However, much shorter durations of hyperoxia exposure (such as a window spanning the "peak" period of secondary septation in mice; say P3-P7) would be sufficient to recapitulate the lung histopathological characteristics of BPD. Such a systematic study examining the effects of a defined oxygen concentration over discrete windows of postnatal lung development in rodents has yet to be performed. Thus, whereas the use of mouse and rat models is widespread, these models are not without substantial drawbacks leading some investigators to explore other experimental animal models of preterm birth and BPD.Table 2Variance in oxygen-exposure protocols in rodent models of bronchopulmonary dysplasia (*LPS* lipopolysaccharide, *P* postnatal day)Oxygen level (%)Oxygen durationProtocol notesReference40P1-P7Recovery in 21% O~2~ P7-P21Wang et al. [@CR126]50/10P1-P14Oscillation; recovery in 21% O~2~ P14-P21M. Chang et al. [@CR25]60P1-P14Ahlfeld et al. [@CR1]; Belcastro et al. [@CR14]; Masood et al. [@CR73]70P3-P13Bachiller et al. [@CR10]75P1-P7Harijith et al. [@CR42]75P1-P14Monz et al. [@CR78]75P1-P14Prenatal hypoxia (10% O~2~)Gortner et al. [@CR39]75P2-P17Popova et al. [@CR98]75P3-P27Anyanwu et al. [@CR8]80P6-P8Weichelt et al. [@CR129]80P1-P7Prenatal LPS, recovery in 21% O~2~ P7-P14Lee et al. [@CR63]80P1-P15Dayanim et al. [@CR33]80P1-P7Recovery in 21% O~2~ P8-P21Pham et al. [@CR95]80P1-P28Recovery in 21% O~2~ P28-P56Tibboel et al. [@CR118]85P1-P7James et al. [@CR52]; Koskinen et al. [@CR62]; Witsch et al. [@CR133], [@CR134]85P2-P9Park et al. [@CR94]85P1-P10Madurga et al. [@CR67]85P1-P14Ahlfeld et al. [@CR1]; Britt et al. [@CR21]; James et al. [@CR52]; Raffay et al. [@CR100]85P4-P14Alphonse et al. [@CR7]85P2-P8Recovery in 21% O~2~ P8-P16Park et al. [@CR94]85P1-P14Recovery in 21% O~2~ P14-P28James et al. [@CR52]; Raffay et al. [@CR100]; Rieger-Fackeldey et al. [@CR105]85/gradientP1-P2885% O~2~ P1-P14, followed by gradient from 85% O~2~ to 21% O~2~ between P14 and P28Rieger-Fackeldey et al. [@CR105]90P3-P10Recovery in 21% O~2~ P10-P14Ramachandran et al. [@CR101]90P1-P14Ahn et al. [@CR3]90P2-P15Hummler et al. [@CR49]90P1-P14Recovery in 21% O~2~ P14-P15Alapati et al. [@CR4]90P1-P15Sutsko et al. [@CR115]90P2-P15Recovery in 21% O~2~ P15-P28Miranda et al. [@CR76]90P1-P15Recovery in 21% O~2~ P15-P29Sutsko et al. [@CR115]95P1-P7Initiated pre-natallyRichter et al. [@CR104]90/60P1-P2190% O~2~ P1-P14, 60% O~2~ P14-P21Y.S. Chang et al. [@CR26]95P4-P14Alphonse et al. [@CR7]95P1-P14Alphonse et al. [@CR7]; McKenna et al. [@CR75]; Vadivel et al. [@CR122]95P1-P6Recovery in 21% O~2~ P6-P21Sakurai et al. [@CR107]95P1-P7Recovery in 21% O~2~ P7-P56Ahlfeld et al. [@CR2]100P1-P3.5Kawamura et al. [@CR58]100P1-P7Sureshbabu et al. [@CR114]100P1-P7With LPS applicationSyed and Bhandari [@CR116]100P1-P10Bhattacharya et al. [@CR16]; Martin et al. [@CR71]; Wagenaar et al. [@CR124], [@CR125]100P1-P4Recovery in 21% O~2~ P4-P56Buczynski et al. [@CR22]

Rabbits represent the middle-ground between small vertebrates such as rats and mice and larger vertebrates such as sheep, pigs and nonhuman primates (Table [3](#Tab3){ref-type="table"}). Unlike mice and rats, rabbit kits can be delivered preterm by caesarian section and can then be subjected to mechanical ventilation (as instrumentation is substantially easier in rabbit kits than in newborn mouse and rat pups). A preterm rabbit model with hyperoxia exposure has been described (Manzano et al. [@CR70]; Richter et al. [@CR104]; Salaets et al. [@CR108]) and the use of preterm rabbits continues to be refined (D'Angio and Ryan [@CR30]; Manzano et al. [@CR70]).Table 3Stages of lung development in larger animals compared with that of humansStageGestational age\
(days)RabbitSheepPigBaboonHumanTerm32147115168--185280EmbryonicUp to 18Up to 40Up to 25Up to 42Up to 42Pseudoglandular21--2440--8022--56Up to 8052--112Canalicular24--2780--11056--9880--120112--168SaccularFrom 27110--130From 99120--140From 168AlveolarFrom 30From 130From 104From 140From 252

Prior to the development of the rabbit model, preterm lambs proved most useful for the modeling of BPD and continue to be used today (Albertine [@CR5]; Brew et al. [@CR20]; Collins et al. [@CR28]; Galinsky et al. [@CR38]; Hillman et al. [@CR46]; Kallapur et al. [@CR57]; Null et al. [@CR89]). The ability to deliver lambs preterm is particularly appealing for translationally relevant modeling of BPD and the larger size of preterm lambs, compared with preterm rabbits, makes instrumentation and mechanical ventilation easier. Clearly, substantial costs are associated with the preterm lamb model. Apart from lambs, renewed interest has been shown in the use of term and preterm piglets to study BPD (Bartlett et al. [@CR13]; Caminita et al. [@CR23]); preterm piglets exhibit ventilation inadequacies, together with clinically comparable risks for the development of respiratory disease syndrome. Thus, piglets represent an alternative to nonhuman primates and lambs.

Primates have been considered the most translationally relevant models for BPD; however, the extraordinary costs of primate studies, together with complex ethical considerations, have led to a decline in the use of primates to model BPD. Two widely used preterm primate models are available (Yoder and Coalson [@CR136]): (1) the 140-day premature baboon model in which preterm baboons are ventilated with high pressures and an FiO~2~ of up to 100 % oxygen for several days is believed histopathologically to mimic "old BPD" (Escobedo et al. [@CR35]); (2) the 125-day premature baboon model in which preterm baboons are ventilated with low tidal volume or nasal continuous positive airway pressure and an FiO~2~ tailored to individual need (up to and beyond 28 days) is believed to mimic more closely "new BPD" (Coalson et al. [@CR27]; Maniscalco et al. [@CR69]). The latter model is occasionally combined with intrauterine exposure to *Ureaplasma*, which frequently results in preterm labor (Yoder and Coalson [@CR136]). The relative phylogenetic closeness of non-human primates to humans, compared with rodents and the ability to deliver non-human primates pre-term have clear advantages for translational research into new BPD. Primates are also often susceptible to the same or related viruses that complicate clinical BPD. For example, newborn baboons can be infected with RSV and also develop pathological features consistent with RSV infection in human neonates (Papin et al. [@CR93]). This is important, since RSV remains an important clinical problem in a neonatal intensive care setting (Carpenter and Stenmark [@CR24]). In addition to clinical and anatomic parallels, non-human primates may be more useful for the study of the long-term sequelae of BPD associated with pre-term birth, including extra-pulmonary sequelae such as neurodevelopmental outcomes, since cognition studies on baboons are well established (Zürcher et al. [@CR138]). From a translational medicine point of view (for example, the assessment of novel therapeutic approaches or the assessment of long-term neurodevelopmental outcomes), the baboon models are unquestionably an ideal model, despite grave ethical concerns and considerable cost. In contrast, for the study of pathogenic pathways, whereby artificial modulation of gene expression is required implicate causality, rodent models remain the method of choice in terms of cost, convenience and tool availability.

In summary, a spectrum of experimental animals has proved useful as model organisms to study BPD, with particular advantages and disadvantages associated with the use of the various model organisms. Given issues of cost, ethics, time and the availability of transgenic animals, the mouse will probably remain the most widely used model for BPD. Whereas hyperoxia and mechanical ventilation have been highlighted as the predominant injurious stimuli for BPD models, much scope remains for an improvement of the way that we induce arrested lung development in BPD models. In this respect, much interest has been shown in sterile and infection-driven inflammation, such as intrauterine inflammation, either singly or in combination with mechanical ventilation or hyperoxia exposure, as a "second hit" (Collins et al. [@CR28], [@CR29]; Yoo et al. [@CR137]). These inflammation-based models are important and clinically relevant BPD models that demand more development and increased use.

Assessment of lung structure: stereological and three-dimensional approaches {#Sec3}
============================================================================

Most BPD models today are employed in studies involving perturbations to the development of lung structure. Of note at this junction, the clinical definition of BPD does not in any way include structural elements of lung development. In a neonatal intensive care setting, the diagnosis of BPD is currently based on the need for supplemental oxygen for at least 28 days after birth and its severity is graded according to the respiratory support required at 36 postmenstrual weeks (Jobe [@CR53], [@CR54]). This does not directly take into account lung structure or perturbations to lung development. Nevertheless, most experimental investigations address the mechanisms underlying stunted lung development and exploit animal models to explore candidate interventions with the aim of promoting lung growth and alveolarization. Thus, the ability effectively to quantify changes in lung structure, most importantly with regard to the size and abundance of the alveoli, the gas-exchange surface area, the vascularization of the lung and the thickness of the septal walls, is clearly important.

The quantification of lung structure is currently undergoing a revolution. Historically, structural analysis of the lung has been undertaken in paraffin-embedded lung tissue and lung structure was analyzed through the determination of the mean linear intercept (MLI) and radial alveolar count (RAC) as surrogates of the size of the alveoli (Silva et al. [@CR111]). These determinations are generally made by direct measurements of the distance between adjacent walls of an alveolus by means of a slide rule. The thickness of the alveolar wall can be similarly measured by visual inspection; however, both approaches are not unbiased. Of greater concern is the distortion of the lung structure that occurs during the tissue processing, namely, the dehydration and rehydration of the lung for paraffin embedding (Schneider and Ochs [@CR110]). These are important concerns, although we must also acknowledge that these more classical approaches form the basis of most of the important observations made to date regarding not only pathological mechanisms of BPD but also drug discovery (Liao et al. [@CR65]; Olave et al. [@CR92]; Schneider and Ochs [@CR110]; Tibboel et al. [@CR117]). To address concerns about bias in analyses and the generation of artifacts during tissue processing, much effort has been expended on replacing paraffin embedding with embedding in plastic resins, together with the treatment of lung tissue with osmium and uranium in order to preserve lung structure (Schneider and Ochs [@CR110]). Additionally, design-based stereology methodologies are unbiased, have higher precision (Schneider and Ochs [@CR109]; Tschanz et al. [@CR119]), and thus represent an advance over the classical MLI and RAC methods (Mühlfeld and Ochs [@CR83]; Ochs and Mühlfeld [@CR91]). Design-based stereology has recently been applied to the analysis of lung structure in newborn mice (Madurga et al. [@CR67], [@CR68]; Mižíková et al. [@CR77]) and rats (Tschanz et al. [@CR120]) and these technologies continue to evolve. Whereas the estimation of alveoli number, gas-exchange surface area and the thickness of the septal wall has developed well, the quantification of vascular structure remains under-developed. Historically, surrogate measures for capillary "density" have been the quantification of immune-histochemical staining of endothelial cell markers in low-power microscopic fields. However, this approach is fraught with pitfalls. Recent work addressing the quantification of capillaries in the lung by using a stereological approach is an important step in the right direction (Knust et al. [@CR60]; Mühlfeld [@CR82]; Willführ et al. [@CR132]) and will no doubt continue to be refined.

If we remain with the topic of microscopy, although not in a quantitative sense, recent exciting studies concerning the three-dimensional reconstruction of serial sections of lungs from patients with BPD have revealed the presence of intrapulmonary anastomoses that would not have been detected in two-dimensional microscopy studies (Galambos et al. [@CR37]). This highlights the tremendous utility of the three-dimensional visualization of lung structures in aberrantly developing lungs. One exciting recent report addresses the three-dimensional study of alveologenesis in mice undergoing normal lung development (Branchfield et al. [@CR18]). These types of approaches have not been employed in lung tissue taken from animal models of BPD but this remains on the "to do list". Furthermore, the availability of transgenic driver mice with facilitated fluorescent labeling of discrete cell types in the lung should allow for studies of cell-cell interactions during lung development. Such an experimental set-up might be used to explore endothelial-epithelial contact and whether these contacts are preserved under conditions of stunted lung growth and blunted alveolarization.

In vitro studies {#Sec4}
================

The development of the three-dimensional architecture of the alveolus demands that alveolarization is studied in intact living animals. However, elements of alveolarization can also be studied in ex vivo tissue from animal models of BPD. An increasing number of reports are appearing in the literature detailing such ex vivo studies. These approaches include the use of co-cultures (Greer et al. [@CR40]; Lewis et al. [@CR64]; Pieretti et al. [@CR96]) to address cell-cell interactions and cell phenotypic transformation during alveolarization, plus in-vitro-generated lung organoids that appear to undergo processes akin to alveolarization (Dye et al. [@CR34]; Quantius et al. [@CR99]). Evidence has also been presented that lung sections harvested from developing mouse lungs and maintained in culture continue to undergo secondary septation (Pieretti et al. [@CR96]). This provides a potentially exciting means of intervening in developmental and pathogenic pathways; such intervention cannot be performed in living animals for reasons of toxicity. These cultured lung explants can be manipulated, for example, through artificial stretch (Davidovich et al. [@CR31]), which might be used to mimic the impact of mechanical ventilation in vitro. The wide availability of cell-type-specific mouse driver lines has introduced the possibility of directly assessing communication between specific cell types during alveolarization, for example, in the in vitro alveolarization studies mentioned above and also by using the previously described organoid systems in which cells derived from particular driver lines can be recombined in vitro. This might be particularly relevant, for example, to the study of the various fibroblast lineages, such as platelet-derived growth factor receptor (PDGF)-α-labeled fibroblasts, including the PDGFRα^hi^ and PDGFRα^low^ subpopulations of lung fibroblasts that have been accredited with different signaling roles in vivo during lung alveologenesis (McGowan and McCoy [@CR74]; Ntokou et al. [@CR88]; Ruiz-Camp and Morty [@CR106]).

Perspective: where do we go from here? {#Sec5}
======================================

The modeling of BPD in animals can be improved and developed in many areas. Use of oxygen as an injurious stimulus is likely to remain a key driver of pathology in experimental animal models of BPD, irrespective of whether low levels (40 % O~2~) or high levels (85 % O~2~) of oxygen are employed. Much scope remains for the improvement of the pure hyperoxia-based models. A very large range of oxygen concentrations have been employed, from 40 % O~2~ to 100 % O~2~, in a variety of exposure protocols, with and without a "second hit", which has both advantages and disadvantages. Amongst the advantages is that much has been learnt about how (much) oxygen injures the developing lung. However, the use of a broad range of oxygen exposure protocols has also yielded data (and conclusions) from various investigators in the field but these data are difficult to compare side-by-side. A systematic comparison of hyperoxia exposure protocols would be a most useful addition to the body of literature on animal models of BPD, as would a comparison of the effects of hyperoxia on different mouse strain backgrounds. The further development of translationally relevant "two-hit" models remains a priority area in experimental animal studies on BPD, as does the technological development of mechanical ventilation and instrumentation of very small newborn rodents.

As highlighted above, the clinical definition of BPD relates to a need for -- and the degree of -- oxygen supplementation at defined time-points during postnatal life. Lung structure is not considered within that definition. The lack of physiological studies on respiratory function in animal models of BPD is remarkable and warrants attention. Some investigators have taken steps to address the relationship of lung structure to the functional impairment of respiratory function (Ahlfeld et al. [@CR2]) and more studies along these lines are urgently needed. The delineation of the degree of the stunting to alveolarization that results in an appreciable impact on gas-exchange physiology in experimental animal models of BPD would be welcome.

The rapid pace of technological development of in vivo imaging, microscopy and computational analysis highlights the utility of these approaches to the study of aberrant lung development in experimental animal models. Notable amongst these is the three-dimensional reconstruction of pathology samples, as this method might reveal anatomical disturbances not evident from two-dimensional analyses. The ability to manipulate lung sections ex vivo in cell culture brings with it new possibilities for the analysis and intervention in lung development pathways; such investigations might not be possible in intact living animals.

As a final point, we also need to broaden our horizons, both beyond the immediate post-natal period and beyond the lung. BPD is known to have sequelae that persist into adulthood and yet, our understanding of the long-term consequences of exposure to hyperoxia, pulmonary infection and inflammation and mechanical ventilation in neonates remains relatively understudied. This is a matter of intensive investigation by some groups, such as that of Michael O'Reilly at the University of Rochester and further exploration of the way that an insult to the developing lung in the postnatal period impacts lung (and general) health in later life is an important area for future work involving the use of experimental animal models of BPD. If we move beyond the lung, neonates with BPD are known to be at risk of serious extra-pulmonary morbidities, including (but not limited to) adverse neurodevelopmental outcomes and retinopathy of prematurity. Important work to address extra-pulmonary morbidity in a hyperoxia-based model of BPD in rodents has now started to emerge (Bravo-Nuevo et al. [@CR19]; Poon et al. [@CR97]). These issues have hardly been studied at all in experimental animal models of BPD and would most likely yield some exciting experimental data.

Summary: neglected areas and urgent needs {#Sec6}
=========================================

The application of animal models for the study of BPD continues to be refined and improved. Several neglected areas currently warrant attention by investigators. (1) Whereas the diversity of animal models of BPD represents a strength of the field, the lack of standardization of the rodent models, in particular, the hyperoxia-based rodent models, can be problematic. Ideally, optimization studies would identify as low an FiO~2~ as possible (which would be in agreement with clinical practice and would embrace concerns about animal welfare) that still recapitulates the pathological hallmarks of BPD. Studies that systematically compare, side-by-side, the impact of diverse oxygen exposure protocols on lung alveolarization are needed. In this respect, the long-term consequences of perturbed lung development in the immediate post-natal period will be an important aspect to address in animal models. (2) The analysis of lung structure has rapidly developed over the past few years, with increased implementation of design-based stereological approaches for the analysis of selected elements of lung structure, for example, the alveoli. However, the stereological analysis of lung vascular development, in particular, the capillaries, remains under-developed. Given that perturbed vascular development is a complication of both clinical and experimental BPD, further refinement of the analysis of lung vascular structures is a priority area. With regard to imaging, the development of alternative approaches to the quantification of lung structure would be desirable. Amongst these are refinement in the visualization and analysis of lung structure in three dimensions and radiological approaches to facilitate serial measurement of the development of the lung in the same animal over an experimental time-course. (3) Although many studies addressing the pathogenesis and management of BPD in animal models utilize a structural analysis of the lung as a primary readout, few studies support these structural analyses with physiological readouts of gas exchange and lung function. Lung function analyses are routinely performed in studies on adult experimental animals, for example, by utilizing the FlexiVent system or whole-body plethysmography; however, these approaches have not been adapted to newborn or juvenile (developing) animals, largely because of technical limitations. The inclusion of lung function data is highly desirable in future studies utilizing animal models of BPD. (4) Given that clinical BPD has a massive impact on several extra-pulmonary issues, including retinopathy and neurodevelopmental outcomes, we urgently need to consider extra-pulmonary effects in animal models of BPD. Thus, much exciting work remains to be done!

Open Access funding provided by Max Planck Society. This study was financially supported by the Max Planck Society, by Rhön Klinikum grant Fl_66, by the Federal Ministry of Higher Education, Research and the Arts of the State of Hessen "LOEWE Programme", by the German Center for Lung Research (Deutsches Zentrum für Lungenforschung), by the German Research Foundation (Deutsche Forschungsgemeinschaft) through Excellence Cluster EXC147, Collaborative Research Center SFB1213/1, Clinical Research Unit KFO309/1 and by individual research grant Mo 1789/1.
